- Home
- / Alar Pharmaceuticals
Alar Pharmaceuticals
Stock Price
NT$169
2024-10-29
Market Capitalization
NT$11.1 B
2024-10-29
Revenue
NT$2.8 M
FY, 2025
Alar Pharmaceuticals Summary
Company Summary
- Overview
- Alar Pharmaceuticals is a new drug development company. It offers opioid use disorder, chronic pain, major depressive disorder, and other services.
- Type
- Public
- Status
- Active
- Founded
- 2016
- Website
- http://alarpharm.com
- Cybersecurity rating
Table of Contents
Alar Pharmaceuticals Financials
Summary Financials
- Revenue (Q1, 2026)
- NT$250.0K
- Gross profit (Q1, 2026)
- NT$1.9M
- Net income (Q1, 2026)
- (NT$35.2M)
- Cash (Q1, 2026)
- NT$1.8B
- EBIT (Q1, 2026)
- (NT$64.1M)
- Enterprise value
- $9.3B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026